In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Intelect Medical Inc.

http://www.intelectmedical.com

Latest From Intelect Medical Inc.

Neuromodulation Start-Ups: Abundant Funding, Slow Exits

The field of neuromodulation has produced numerous start-ups and a decent amount of fundraising activity over the past six years, but exits are scarce.

Medical Device Deals

Deep Brain Stimulation Probes New Frontiers

Deep brain stimulation (DBS) currently comprises only about a quarter of the worldwide neuromodulation device market, but growth in this segment is strong. Both large and small competitors have targeted DBS, which has the potential to address a number of highly prevalent and underserved diseases and disorders.

Medical Device

New Products In Brief

FDA clears skin-cancer companion diagnostic. Medtronic announces two AAA-related approvals. OrbusNeich launches dual-therapy stent outside the U.S. More new products.

Medical Device Launches

Neuromodulation Market: Innovation Brings High-Growth Rewards

Medical Device North America
See All

Company Information

  • Industry
  • Medical Devices
    • Implantable Devices
UsernamePublicRestriction

Register